Aggregate Risk of Major Adverse Events in Patients Undergoing Neoadjuvant Chemotherapy and Surgical Resection for Pancreatic Adenocarcinoma. (2022) - Robbins, K.; Grierson, P.; Sanford, D.; Fields, R.; Hawkins, W.; Strasberg, S.; Hammill, C.